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Abstract
The hypothalamus in the brain is the main center for appetite control and integrates signals from adipose tissue and the
gastrointestinal tract. Antidepressants are known to modulate the activities of hypothalamic neurons and affect food intake,
but the cellular and molecular mechanisms by which antidepressants modulate hypothalamic function remain unclear. Here
we have investigated how hypothalamic neurons respond to treatment with antidepressants, including desipramine and
sibutramine. In primary cultured rat hypothalamic cells, desipramine markedly suppressed the elevation of intracellular Ca
2+
evoked by histamine H1 receptor activation. Desipramine also inhibited the histamine-induced Ca
2+ increase and the
expression of corticotrophin-releasing hormone in hypothalamic GT1-1 cells. The effect of desipramine was not affected by
pretreatment with prazosin or propranolol, excluding catecholamine reuptake activity of desipramine as an underlying
mechanism. Sibutramine which is also an antidepressant but decreases food intake, had little effect on the histamine-
induced Ca
2+ increase or AMP-activated protein kinase activity. Our results reveal that desipramine and sibutramine have
different effects on histamine H1 receptor signaling in hypothalamic cells and suggest that distinct regulation of
hypothalamic histamine signaling might underlie the differential regulation of food intake between antidepressants.
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Introduction
Appetite is subjected to multiple layers of regulation by several
neuropeptides and neuromodulators in a number of regions of the
hypothalamus, including the arcuate nucleus, paraventricular
nucleus, and lateral hypothalamic area. In particular, the arcuate
nucleus in the hypothalamus is a target for leptin produced from
adipose tissue and insulin from the pancreas, as well as ghrelin
from the gastrointestinal tract. Subsequently, neuropeptide Y and
alpha-melanocortin are released from the arcuate nucleus to
modulate neuronal activity in the paraventricular nucleus and
lateral hypothalamus [1]. Numerous intrinsic and extrinsic factors
that modulate hypothalamic neuronal activity are known to affect
food intake. For example, drugs affecting adrenergic and
serotonergic signaling (such as phentermine, phenylpropanol-
amine, amphetamine, and fenfluramine) have been shown to
either decrease appetite or increase satiety [2,3]. Likewise, food
intake behavior is influenced by chemicals or drugs that block the
reuptake or enhance the release of neurotransmitters, such as
serotonin or catecholamines [4,5].
However, the exact mechanisms responsible for the modulation
of food intake behavior by these neurotransmitters or chemicals
are not fully understood. In fact, decoding the molecular and
cellular mechanisms that underlie food intake can be quite
challenging. Food intake is a complicated process regulated by
several parameters, such as hedonic properties of rewards and
energy metabolism, each of which consists of complex neural
circuits with distinct responses and activities. To overcome this
limitation, we sought out for methods to simplify the model system
and preferentially focused on hypothalamus, which is one of the
most significant food intake modulating centers in the brain, and
desipramine, which is a typical appetite-affecting chemical.
Desipramine is an oral antidepressant and a member of the
tricyclic antidepressant family, which is known to block norepi-
nephrine reuptake and enhance catecholamine signaling. Desi-
priamine causes opposite effects on appetite, as it increases food
intake, as opposed to other antidepressants, which in many cases
decrease food intake [4,6–8]. Sibutramine is also an inhibitor of
serotonin and norepinephrine reuptake, but it suppresses appetite
and was approved for the treatment of obesity [2]. The present
study compares the mechanism of action of these two transmitter
reuptake blockers and investigates their roles in the regulation of
histamine signaling in hypothalamic cells. This study shows that
desipramine specifically modulates histamine H1 receptor signal-
ing in hypothalamus cells, an effect which could not be mimicked
by sibutramine. These different effects of desipramine and
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e36185sibutramine on hypothalamic signaling might underlie their
distinct influences on physiological responses, such as modulation
of appetite and food intake behavior.
Results
Desipramine inhibits the increase in cytosolic Ca
2+
concentration ([Ca
2+]i) induced by histamine in rat
hypothalamic cells
To investigate neurotransmitter receptor-mediated signaling in
the hypothalamus, we prepared primary cultures of rat hypotha-
lamic cells, including cells from the paraventricular nucleus, an
appetite modulation center. Approximately 32% of cultured cells
showed an increase in intracellular calcium concentration ([Ca
2+]i)
in response to histamine (Fig. 1A–B). It is so far not completely
understood how changes in cytosolic Ca
2+ levels in the
hypothalamus affect neural function and modulate food intake
behavior. Nevertheless, we monitored [Ca
2+]i, as an indicator of
histamine signaling, as cytosolic calcium increase is perhaps the
best-established cellular response downstream of histamine re-
ceptor activation. Pre-incubation of the cells with desipramine
(30 mM) markedly inhibited the subsequent histamine-induced
[Ca
2+]i increase (Fig. 1C). Desipramine itself did not have any
effect on basal [Ca
2+]i level.
As only about one third of the total population of the primary
cultures responded to histamine, we tested the effect of de-
sipramine on histamine signaling in the GT1-1 hypothalamic cell
line in order to circumvent the inherent heterogeneity of the
primary cultures. GT1-1 cell line is an immortalized hypothalamic
neuronal cell line established by the introduction of SV40 antigen
in the promoter/enhancer domains of the GnRH gene [9].
Recently, many studies have suggested the role of GnRH secreting
neurons in the modulation of food intake, and GT1-1 cells have
been used as a model system to investigate the mechanisms
underlying food intake, as exemplified by a study of alpha-
melanocortin signaling [10–11]. As with the primary cultured rat
cells, histamine-induced increases in [Ca
2+]i were inhibited by
pretreatment with desipramine in GT-1 cells (Fig. 2A); the
inhibitory effect was observed in a concentration-dependent
manner with an of IC50 3.8760.98 mM (Fig. 2B). We then
monitored the effect of histamine on the expression of corticotro-
pin-releasing hormone (CRH), one of the well-characterized
anorexic hormones [12], which has recently been suggested to
modulate food intake downstream of G protein-coupled receptors,
such as angiotensin II receptors [13]. Desipramine also inhibited
the increase in CRH production induced by histamine (Fig. 2C).
However, desipramine, even at high concentrations, did not affect
[Ca
2+]i increase induced by application of extracellular ATP
(300 mM) in GT1-1 cells (Fig. 2D), suggesting that desipramine
specifically regulates calcium signaling downstream of histamine.
Desipramine specifically regulates calcium signaling
downstream of H1 receptor
Two subtypes of histamine receptors, H1 and H3, are known to
modulate appetite. To investigate which histamine receptors are
functionally expressed in primary hypothalamic cells and GT1-1
cells, we tested the effects of specific antagonists against histamine
Figure 1. Desipramine inhibits histamine-induced [Ca
2+]i rise in primary cultured rat hypothalamic cells. (A) Fura-2-loaded primary
cultured rat hypothalamic cells were challenged with 100 mM histamine. The change in fluorescence ratio of F340/F380 was measured. Gray traces
represent the individual responses from each dissociated cell, and their average is depicted with a black trace. (B) Histogram of net changes in
fluorescence ratio triggered by 100 mM histamine. (C) Primary cultured rat hypothalamic cells were challenged with 100 mM histamine (black bar) in
the presence or absence of 30 mM desipramine (white bar). Typical [Ca
2+]i traces from more than three separate experiments are presented. All results
were reproducible.
doi:10.1371/journal.pone.0036185.g001
Desipramine in Rat Hypothalamic Cells
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receptor-specific antagonist) decreased the increase in [Ca
2+]i
induced by histamine, whereas ranitidine (1 mM, histamine H2-
specific antagonist) and thioperamide (1 mM, histamine H3 and
H4 receptor-specific antagonist) had little effect in GT1-1 cells
(Fig. 3A, B, C). Histamine (100 mM) did not elevate cytosolic
cAMP, which indicates the lack of functional H2 receptors that are
linked to adenylyl cyclase (Fig. 3D). By contrast, there was
a marked elevation of cAMP in response to NDP-MSH (20 mM),
an agonist for the adenylyl cyclase-coupled MC4 receptor, which
is known to be activated by a-melanocortin (one of appetite-
modulating neurotransmitter). In primary rat hypothalamic cells,
we also found that preincubation with chlorpheniramine (1 mM)
completely blocked histamine-induced [Ca
2+]i increase (Fig. 3E).
The effect of desipramine on histamine-induced [Ca
2+]i
increase is not affected by adrenergic receptor
antagonists
Certain tricyclic antidepressants, including desipramine, are
known to block the reuptake of catecholamines in catecholamine-
secreting neurons. It is thus possible that blockade of catechol-
amine reuptake by desipramine results in the accumulation of
Figure 2. Desipramine inhibits the histamine-induced [Ca
2+]i rise and CRH expression in GT1-1 cells. (A) Fura-2-loaded GT1-1 cells were
challenged with 100 mM histamine in the absence (light gray trace) or presence of 3 mM (gray trace) or 10 mM (black trace) desipramine. Cytosolic
Ca
2+ concentrations were measured. Typical [Ca
2+]i traces from more than seven separate experiments are presented. (B) Cells were pretreated with
various concentrations of desipramine before histamine (100 mM) treatment. The net increases in histamine-induced [Ca
2+]i are expressed with the
mean 6 SEM. The experiment was performed independently three times. (C) GT1-1 cells were challenged with 100 mM histamine (HA) in the absence
or presence of 10 mM desipramine (Desi), then total RNA was isolated from each sample, reverse transcribed and used to determine the amount of
gene expression of CRH using real-time RT-PCR. The mean 6 SEM values of fold induction from three independent experiments are shown. *P,0.05,
compared to the response with histamine (HA). (D) Cells were challenged with 300 mM ATP in the presence (black trace) or absence (gray trace) of
30 mM desipramine. Typical [Ca
2+]i traces from more than three separate experiments are presented. All results were reproducible.
doi:10.1371/journal.pone.0036185.g002
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receptors. To examine if the regulation of histamine signaling by
desipramine is mediated by adrenergic receptors secondary to its
inhibitory effect on catecholamine reuptake, we applied prazosin
and propranolol, specific antagonists for a- and b-adrenergic
receptors, respectively. Pre-incubation of the cells with propranolol
(100 mM) (Fig. 4A) or prazosin (30 mM) (Fig. 4B) did not affect the
inhibitory effect of desipramine (30 mM) on histamine-induced
Figure 3. Histamine H1 inhibitor eliminates histamine-induced [Ca
2+]i rise in GT1-1 cells. (A–B) Fura-2-loaded GT1-1 cells were challenged
with 100 mM histamine in the presence of 1 mM chlorpheniramine (A) and 1 mM thioperamide (B). Typical [Ca
2+]i traces from more than seven
separate experiments are presented. (C) Cells were pretreated with vehicle (Veh), 1 mM chlorpheniramine (CPR), 1 mM thioperamide (Thio), or 30 mM
ranitidine (Ran) before histamine (100 mM) treatment. The net increases in histamine-induced [Ca
2+]i are expressed with the mean 6 SEM. The
experiment was independently performed three times. (D) Cells were stimulated with 1 mM NDP-MSH and/or 100 mM histamine (HA) in the presence
of 5 mM Ro 20–1724 for 15 minutes; cAMP production was then monitored. Each point is the mean 6 SEM of a triplicate assay. The data are
representative of three separate experiments. (E) Fura-2-loaded primary cultured rat hypothalamic cells were challenged with 100 mM histamine
(black bar) in the presence or absence of 1 mM chlorpheniramine (CPR, white bar). Typical [Ca
2+]i traces from more than three separate experiments
are presented. The results were reproducible.
doi:10.1371/journal.pone.0036185.g003
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2+]i increase. To test the possible involvement of other second
messengers, we examined if desipramine had any effects on
cytosolic cAMP levels. Desipramine (30 mM) itself did not alter
cytosolic cAMP levels, and failed to affect the increase in cAMP
evoked by either forskolin (3 mM) or isoproterenol (1 mM)
(Fig. 4D). These results exclude the involvement of adrenergic
receptor activation from desipramine-induced inhibition of
histamine signaling.
Sibutramine has no effect on histamine-induced increase
in cytosolic Ca
2+ concentration
We next examined the effects of sibutramine and clozapine on
histamine signaling and compared them with that of desipramine.
Clozapine is known to inhibit histamine signaling and sub-
sequently induce hyperphagia [14]. Consistent with the report
[14], we observed that clozapine substantially blocked the [Ca
2+]i
increase induced by histamine (Fig. 5B). By contrast, sibutramine
had no effect on the histamine-induced [Ca
2+]i increase in GT1-1
Figure 4. Propranolol and prazosin did not reverse desipramine-mediated inhibition of histamine-induced [Ca
2+]i rise in GT1-1
cells. (A) Fura-2-loaded GT1-1 cells were preincubated with (black trace) or without (gray trace) 30 mM propranolol and then challenged with 30 mM
desipramine (Desi) and 100 mM histamine, sequentially. The histamine-induced [Ca
2+]i increase without any drug pretreatment is depicted as control
(light gray trace). Typical [Ca
2+]i traces from more than seven separate experiments are presented. (B) Cells were preincubated with (black trace) or
without (gray trace) 30 mM prazosine and then challenged with 30 mM desipramine (Desi) and 100 mM histamine sequentially. The histamine-induced
[Ca
2+]i increase without any drug pretreatment is depicted as a control (light gray trace). Typical [Ca
2+]i traces from more than seven separate
experiments are presented. (C) The net increases in histamine-induced [Ca
2+]i in A and B with 30 mM desipramine (Desi), 30 mM prazosine (Praz), and
30 mM propranolol (Propr) is depicted with the mean 6 SEM. The experiment was independently performed three times. (D) Cells were stimulated
with 3 mM forskolin, 30 mM desipramine (Desi), or 1 mM isoproterenol (Isoprot) in the presence of 5 mM Ro 20–1724 for 15 minutes; cAMP production
was then monitored. The cAMP levels were measured. Each point is the mean 6 SEM of a triplicate assay. The data are representative of three
separate experiments. All results were reproducible. n.s., not statistically significant with P.0.05.
doi:10.1371/journal.pone.0036185.g004
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of histamine-evoked [Ca
2+]i increase induced by clozapine,
sibutramine did not alter the calcium response even at extremely
high concentrations (300 nM and 3 mM shown in Fig. 5C; 1 mM,
data not shown).
Desipramine but not sibutramine increases AMPK
phosphorylation
Food intake behavior can be modulated by the activity of
hypothalamic AMPK [15], and pathways that control AMPK
activation have been suggested as critical cellular and molecular
mechanisms underlying the modulation of feeding behavior by
anti-psychotic drugs, such as clozapine [14]. We thus decided to
monitor the effect of desipramine on hypothalamic AMPK
activity, which is known to be modulated by Ca
2+/calmoduline-
dependent kinase in response to changes in the cytosolic calcium
level. Treatment with desipramine, clozapine, and chlorphenir-
amine significantly increased the level of phospho-AMPK,
whereas sibutramine and thioperamide had little effect (Fig. 6).
In addition, when subthreshold concentrations of desipramine,
clozapine, or chlorpheniramine were treated with excessive
histamine, there was no change in the level of phospho-AMPK
(Fig. 6).
Discussion
In the central nervous system, histamine is secreted from the
tuberomammillary nucleus, spreads throughout the brain, and
modulates energy metabolism and the sleep cycle [16]. Most
notably, histamine is known to control appetite by binding to H1
receptors in the paraventricular nucleus and the ventromedial
hypothalamus [17,18]. Activation of hypothalamic H1 receptors
has been reported to be elevated in patients with anorexia nervosa
[19]. Histamine is also known to play a major part in altering
signaling downstream of other appetite modulators, such as leptin
[20], glucagon-like peptide 1, CRH [21], and thyrotropipn-
releasing hormone [22]. Moreover, increased food intake occurs as
a side effect of anti-histamine medications, which target the
histamine H1 receptor [23,24].
In this study, we reveal that desipramine, but not sibutramine,
inhibits histamine signaling in both primary rat hypothalamic cells
and GT1-1 cells. Desipramine blocked the histamine-induced
[Ca
2+]i increase in a concentration-dependent manner. Adrener-
gic receptor blockers did not reverse the effect of desipramine,
suggesting that modulation of histamine H1 receptor signaling by
desipramine is independent from its known role to prevent
norepinephrine reuptake. Desipramine also increased the level of
AMPK phosphorylation, an effect which was not mimicked by
sibutramine. Together, we suggest that differential cellular
responses induced by the treatment of desipramine and sibutra-
mine, such as modulation of calcium signaling and AMPK
activation, might provide an explanation for their opposing effects
on food intake and weight gain.
Histamine H3 receptor subtype is also associated with the
modulation appetite and food intake. Histamine H3 receptor
activation increases appetite [25], whereas H3 antagonists cause
a side effect of decreased food intake [26,27]. GT1-1 cells,
however, express H1 but lack H3 receptors [28], excluding the
involvement of the H3 subtype in the histamine-induced Ca
2+
response regulated by desipramine (Fig. 2 and 3).
Desipramine is a member of the tricyclic antidepressant family
which is well known to block catecholamine reuptake. In both
primary hypothalamic cells and GT1-1 cells, b-adrenergic
receptor activation triggers the secretion of gonatotropin-releasing
hormone; an effect which is mimicked by isoproterenol and
inhibited by propranolol [29]. However, we found that pre-
treatment with prazosin or propranolol, antagonists for a- and b-
adrenergic receptors, respectively, did not have any effects on
desipramine-induced modulation of histamine signaling (Fig. 4).
Based on these results, we conclude that desipramine directly
inhibits histamine H1 receptor signaling without the involvement
of adrenergic receptor activation.
Sibutramine and desipramine are known to regulate appetite in
an opposing manner in spite of their pharmacological similarities.
Our results reveal that desipramine, but not sibutramine, inhibits
histamine H1 receptor signaling in hypothalamic cells (Fig. 5). We
also compared the effect of desipramine with another ‘orexigenic’
medicine, clozapine, which is an atypical antipsychotic that causes
increase in appetite as a side effect [30,31]. Clozapine acts on
Figure 5. Clozapine, but not sibutramine, inhibits histamine-
induced [Ca
2+]i rise in GT1-1 cells. (A) Fura-2-loaded GT1-1 cells
were challenged with 100 mM histamine in the absence (gray trace) or
presence (black trace) of 30 mM sibutramine. Typical [Ca
2+]i traces from
more than seven separate experiments are presented. (B) Cells were
challenged with 100 mM histamine in the absence (light gray trace) or
presence of 10 nM (gray trace) or 100 nM (black trace) clozapine.
Typical [Ca
2+]i traces from more than three separate experiments are
presented. (C) Cells were treated with indicated concentrations of
sibutramine (SIB) or clozapine (CLZ) before challenging with 100 mM
histamine. The net increases in histamine-induced [Ca
2+]i are expressed
by mean 6 SEM. The experiment was independently performed three
times. **P,0.01, compared to the response with histamine only (Veh).
All results were reproducible.
doi:10.1371/journal.pone.0036185.g005
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affinity for the histamine H1 receptor [32]. A recent clozapine-
induced hyperphagia study suggested that histamine signaling and
subsequent AMP kinase activation might be responsible for the
modulation of appetite in response to administration of psychiatric
medicines [14]. In our study, clozapine potently inhibited
histamine-induced [Ca
2+]i increase in GT1-1 cells (Fig. 4).
Moreover, we have confirmed that clozapine increases the level
of AMPK phosphorylation (Fig. 6), consistent with a previous
report [14]. Interestingly, desipramine and chlorpheniramine also
induced AMPK phosphorylation, whereas sibutramine and
thioperamide had little effects (Fig. 6). These findings are
essentially in agreement with the changes in histamine-induced
cytosolic Ca
2+ increase. Even though clozapine and desipramine
do not share any structural or pharmacological similarities, it is
interesting to note that the two drugs that inhibit histamine H1
receptor signaling are also associated with increase in appetite.
Taken together, our results suggest that desipramine inhibits
histamine H1 receptor signaling in rat hypothalamic cells and
GT1-1 cells. We showed that desipramine and sibutramine
differentially affect histamine signaling, i.e., histamine-induced
cytosolic Ca
2+ increase, and AMPK activation. These different
cellular responses might provide an explanation for their distinct
influences on food intake and weight gain. At this point, it is
extremely tenuous to conclude that the differential effects of the
two antidepressants on feeding are entirely mediated by histamine
signaling because in vivo studies will be needed to unambiguously
provide a link between certain cellular mechanisms and physio-
logical responses. Nevertheless, our results contribute to a further
understanding of the cellular mechanisms of desipramine. Our
results also imply that histamine receptors might be a potential
clinical target for appetite modulation.
Materials and Methods
Materials
Desipramine, clozapine, carbachol, chlorpheniramine, ranidi-
tine, thioperamide, ATP, thapsigargin and sulfinpyrazone were
purchased from Sigma (St. Louis, MO, USA). Sibutramine was
purchased by Sigma/RBI (Natick, MA, USA). Fura-2/AM was
obtained from Molecular Probes (Eugene, OR, USA). RPMI
1640, DMEM, fetal bovine serum and penicillin/streptomycin
were purchased from GIBCO (Grand Island, NY, USA).
Collagenase P was purchased from Roche Molecular Biochemicals
(Indianapolis, IN, USA). Mouse monoclonal anti-AMPK a were
purchased from Invitrogen, rabbit polyclonal anti-phospho-
AMPK a was from Cell Signaling, and rabbit polyclonal anti-b-
actin was from Abcam.
Cell preparation and culture
The hypothalamic primary culture was performed as previously
described [33]. All animal procedures followed the National
Institutes of Health guidelines, and were approved by the Animal
Care Committee of Seoul National University (SNU-101222-3).
Animal handling was conducted in accordance with national and
international guidelines.
The number of animals used was minimized, and all necessary
precautions were taken to mitigate pain or suffering. One to three-
days-old Sprague-Dawley rats were killed and coronal brain slices
(400 mm thick) containing hypothalamus were prepared. The part
including paraventricular nucleus (about 1 mm
3) was sectioned
and isolated in a 10% fetal bovine serum containing DMEM then
immersed in an ice-cold hank’s balanced salt solution (Welgene,
Daejeon, Korea). Sectioned hypothalamic regions were treated
with 0.125% trypsin-EDTA for 15 min at 37uC before a mechan-
ical dissociation. For the mechanical isolation of hypothalamic
neurons, the trypsinized tissues were triturated several times using
fire-polished glass pipettes of decreasing diameter. Cells were
centrifuged at 800 rpm for 5 min, washed twice and plated on the
cover glass for the experiments. The mouse immortalized
hypothalamic GT1-1 cells were grown in DMEM supplemented
with 10% (v/v) heat-inactivated fetal bovine serum, and 1% (v/v)
penicillin (5,000 U/ml)+streptomycin (5,000 mg/ml) solution. The
cells were cultured in a humidified atmosphere of 95% air and 5%
CO2. The culture medium was changed every two days, and the
cells were subcultured weekly.
Measurement of cytosolic Ca
2+ concentration [Ca
2+]i
The cytosolic Ca
2+ concentration [Ca
2+]i was determined using
the fluorescent Ca
2+ indicator fura-2/AM as previously described
[34]. Briefly, cells were incubated for 50 min at 37uC with 2.5 mM
fura-2/AM in serum-free DMEM. The loaded cells were then
washed twice with a HEPES-buffered solution (140 mM NaCl,
5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and
10 mM HEPES, pH adjusted to 7.4 with NaOH), Locke’s solution
Figure 6. Desipramine, but not sibutramine, inhibits the
phosphorylation of AMPK a. (A) Cells were pretreated with vehicle
(Veh), 10 mM desipramine (Desi), 3 mM sibutramine (Sibu), 100 nM
clozapine (CLZ), 1 mM chlorpheniramine (CPR), or 1 mM thioperamide
(Thio), with or without histamine (100 mM) treatment and, proteins
were subjected to immunoblotting using anti-AMPK a, anti-phospho-
AMPK a and anti-b-actin, as indicated. Anti-AMPK a and anti-b-actin
were used to probe for equal protein loading. The plus and minus
symbols indicate the presence or absence of Histamine (HA). (B)
Relative band intensity of was determined by densitometric analysis of
(A). The results shown are the means 6 SEM of four independent
experiments. ***P,0.005.
doi:10.1371/journal.pone.0036185.g006
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HEPES, 5.0 mM; glucose, 10 mM, pH 7.4 with NaOH) or Ca
2+-
free Locke’s solution (156.2 mM NaCl, 5.6 mM KCl, 1.2 mM
MgCl2, 5 mM HEPES, and 10 mM glucose, pH 7.3). Fura-2 AM-
loaded cells transferred to a poly-l-lysine-coated 25 mm coverslips
for cell attachment for 40 min in incubator, and the coverslips
were mounted onto the chamber (200 mL, total volume). Changes
in fluorescence ratio were monitored by Ca
2+ imaging machine
with MetaFlour software (Molecular Devices, Sunnyvale, CA,
USA) with dual excitation at 340 and 380 nm and emission at
500 nm. Experiments with suspended cells were performed with
the spectrofluorophotometer. In this case, calibration of the
fluorescent signal in terms of [Ca
2+]i was performed as described
in Grynkiewicz et al. [35].
Measurment of [
3H] cAMP
Intracellular cAMP generation was determined by [
3H]cAMP
competition assay in binding to cAMP binding protein as
described previously [34] with some modifications. To determine
the cAMP production, the GT1-1 cells were stimulated with
agonists for 20 min in the presence of the phosphodiesterase
inhibitor Ro 20–1724 (5 mM), and the reaction was quickly
terminated by three repeated cycles of freezing and thawing. The
samples were then centrifuged at 12,000 g for 5 min at 4uC. The
cAMP assay is based on the competition between [
3H]-labeled
cAMP and unlabeled cAMP present in the sample for binding to
a crude cAMP binding protein prepared from bovine adrenal
cortex. Bound [
3H]cAMP in the supernatant was then determined
by liquid scintillation counting. Each sample was incubated with
50 ml[
3H]-labeled cAMP (5 mCi) and 100 ml binding protein for
2h ra t4 uC. Separation of protein-bound cAMP from unbound
cAMP was achieved by absorption of free cAMP onto charcoal
(100 ml), followed by centrifugation at 12,000 g at 4uC. The 200 ml
supernatant was then placed into an eppendorf tube containing
1.2 ml scintillation cocktail to measure radioactivity. The cAMP
concentration in the sample was determined based on a standard
curve and expressed as picomoles per microgram of protein.
Western blot analysis
Proteins were separated by SDS-PAGE and blotted onto
polyvinylidene fluoride (PVDF) membranes. After blocking with
3% BSA in TBS-T (137 mM NaCl, 20 mM Tris-Cl, pH 7.6,
0.1% Tween 20), the blots were incubated with the primary
antibodies, as indicated. The blots were then incubated with
horseradish peroxidase (HRP) conjugated anti-rabbit, or mouse
secondary antibodies (Santa Cruz).
Real-time RT-PCR
The mRNA expression levels of mouse GAPDH and CRH
were measured by real-time RT-PCR. Total RNA was prepared
from the GT1-1 cells. Real-time PCR was performed using the
SYBR Green reagent and an ABI Prism 7500 sequence detection
system (Applied Biosystems, Warrington, UK), with the following
PCR conditions; 50uC for 2 min, 94uC for 10 min, and 40 cycles
of 95uC for 30 sec, followed by 60uC for 1 min. The sequences for
the primers used for PCR were as follows; mouse GAPDH
(forward), 59-AGG TCA TCC CAG AGC TGA ACG-39; mouse
GAPDH (reverse), 59-CAC CCT GTT GCT GTA GCC GTA T-
39; mouse CRH (forward), 59-CCC GCA GCC CTT GAA TTT-
39; mouse CRH (reverse), 59-CGA GCA GCG GGA CTT CTG-
39. The expression level of each gene was normalized to the level
of the GAPDH gene and represented as the fold induction.
Analysis of data
All quantitative data are expressed as means 6 SEM. The
results were analyzed for differences using the unpaired Student’s t
test. We calculated EC50 and IC50 with the Microcal Origin
program (Northampton, MA, USA). Differences were determined
by one-way ANOVA and considered to be significant only for
P,0.05.
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